Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
2(33%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
2
33%
Ph phase_2
3
50%

Phase Distribution

0

Early Stage

3

Mid Stage

0

Late Stage

Phase Distribution5 total trials
Phase 2Efficacy & side effects
3(60.0%)
N/ANon-phased studies
2(40.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

6

all time

Status Distribution
Active(2)
Completed(1)
Other(3)

Detailed Status

unknown3
Recruiting2
Completed1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
2
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 23 (60.0%)
N/A2 (40.0%)

Trials by Status

recruiting233%
unknown350%
completed117%

Recent Activity

Clinical Trials (6)

Drug Details

Intervention Type
DRUG
Total Trials
6